Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_assertion type Assertion NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_head.
- NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_assertion description "[In addition, we found that p16 (INK4a) is also downregulated in immortal cells and that coexpression of CREG1 and p16 (INK4a) , an inhibitor of CDK4/6 and Rb phosphorylation, has a greater effect than either CREG1 and p16 (INK4a) alone to reduce cell growth, induce cell cycle arrest and cellular senescence in immortal LFS fibroblasts, osteosarcoma and fibrosarcoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_provenance.
- NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_assertion evidence source_evidence_literature NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_provenance.
- NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_assertion SIO_000772 21263217 NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_provenance.
- NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_assertion wasDerivedFrom befree-20150227 NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_provenance.
- NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_assertion wasGeneratedBy ECO_0000203 NP301243.RAu0m5iBmhIi-wfeyF6cnHlzyP04iQw_Fm0UBB9V3CYqY130_provenance.